英国研究治理战略。
United Kingdom research governance strategy.
作者信息
Kerrison Susan, McNally Nick, Pollock Allyson M
机构信息
University College London Hospitals NHS Trust, London NW1 2LT.
出版信息
BMJ. 2003 Sep 6;327(7414):553-6. doi: 10.1136/bmj.327.7414.553.
Abstract
The new research governance strategy marks a radical overhaul of the arrangements for medical research in the NHS and academic institutions with far reaching implications for all those taking part in research. The days of registrars and consultants singlehandedly doing research projects are over
摘要
新的研究治理策略标志着英国国家医疗服务体系（NHS）和学术机构中医学研究安排的彻底变革，对所有参与研究的人员都具有深远影响。住院医生和顾问医生单枪匹马开展研究项目的日子已经一去不复返了。
相似文献
1
United Kingdom research governance strategy.英国研究治理战略。
BMJ. 2003 Sep 6;327(7414):553-6. doi: 10.1136/bmj.327.7414.553.
2
View from the research and development office.从研发办公室看到的景色。
BMJ. 2004 Jul 31;329(7460):281-2. doi: 10.1136/bmj.329.7460.281.
3
The other face of research governance.研究治理的另一面。
BMJ. 2004 Jul 31;329(7460):280-1. doi: 10.1136/bmj.329.7460.280.
4
The shifting sands of research ethics and governance: effect on research in paediatrics.研究伦理与治理的变幻莫测：对儿科研究的影响
Arch Dis Child. 2007 Jan;92(1):80-1. doi: 10.1136/adc.2006.101436.
5
Meeting the challenges of research governance.应对研究治理的挑战。
Rheumatology (Oxford). 2005 May;44(5):571-2. doi: 10.1093/rheumatology/keh579. Epub 2005 Mar 9.
6
Reforming clinical research and development in England.改革英国的临床研究与开发。
BMJ. 2003 Sep 6;327(7414):550-3. doi: 10.1136/bmj.327.7414.550.
7
An exercise in fatuity: research governance and the emasculation of HSR.一项愚蠢的行为：研究治理与卫生服务研究的式微
J Health Serv Res Policy. 2006 Oct;11(4):193-4. doi: 10.1258/135581906778476580.
8
Audit, educational development and research: what counts for ethics and research governance?审计、教育发展与研究：伦理与研究治理的关键要素是什么？
Med Teach. 2005 Mar;27(2):99-101. doi: 10.1080/01421590500080949.
9
Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.免除低风险健康和医学研究的伦理审查：比较澳大利亚、英国、美国和荷兰。
Health Res Policy Syst. 2020 Jan 28;18(1):11. doi: 10.1186/s12961-019-0520-4.
10
New governance framework for NHS research aims to stop fraud.英国国家医疗服务体系（NHS）研究的新治理框架旨在杜绝欺诈行为。
BMJ. 2000 Sep 23;321(7263):725.
引用本文的文献
1
Qualitative documentary analysis of guidance on information provision and consent for the introduction of innovative invasive procedures including surgeries within NHS organisations' policies in England and Wales.定性文献分析：英格兰和威尔士国民保健署组织政策中关于提供信息和同意引进创新侵入性程序（包括手术）的指导。
BMJ Open. 2022 Sep 1;12(9):e059228. doi: 10.1136/bmjopen-2021-059228.
2
Research governance impediments to clinical trials: a retrospective survey.临床试验的研究治理障碍：一项回顾性调查。
J R Soc Med. 2007 Feb;100(2):101-4. doi: 10.1177/014107680710000227.
3
Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK?药品的非商业临床试验：它们能在英国当前的研究审批流程中存续下来吗？
J Med Ethics. 2006 Jul;32(7):430-4. doi: 10.1136/jme.2005.015180.
4
From meeting presentation to peer-review publication--a UK review.从会议报告到同行评审发表——一项英国综述。
Ann R Coll Surg Engl. 2006 Jan;88(1):52-6. doi: 10.1308/003588406X83069.
5
Including older people in clinical research.将老年人纳入临床研究。
BMJ. 2005 Nov 5;331(7524):1036-7. doi: 10.1136/bmj.331.7524.1036.
6
The reform of UK research ethics committees: throwing the baby out with the bath water?英国研究伦理委员会的改革：是否因噎废食？
J Med Ethics. 2005 Aug;31(8):487-9. doi: 10.1136/jme.2004.010546.
7
United Kingdom research governance strategy: reforming clinical research and development in England.英国研究治理战略：改革英格兰的临床研究与开发
BMJ. 2004 Jan 3;328(7430):49-50; author reply 50. doi: 10.1136/bmj.328.7430.49-b.
8
Reforming clinical research and development in England.改革英国的临床研究与开发。
BMJ. 2003 Sep 6;327(7414):550-3. doi: 10.1136/bmj.327.7414.550.
本文引用的文献
1
Reforming clinical research and development in England.改革英国的临床研究与开发。
BMJ. 2003 Sep 6;327(7414):550-3. doi: 10.1136/bmj.327.7414.550.
2
Working with the private sector: the need for institutional guidelines.与私营部门合作：制定机构指南的必要性。
BMJ. 2002 Aug 24;325(7361):432-5. doi: 10.1136/bmj.325.7361.432.
3
Two deaths and two lessons: is it time to review the structure and function of research ethics committees?两起死亡事件与两点教训：是时候审视研究伦理委员会的结构与职能了吗？
J Med Ethics. 2002 Feb;28(1):1-2. doi: 10.1136/jme.28.1.1.
4
Regulating health care: from self-regulation to self-regulation?规范医疗保健：从自我监管到自我监管？
J Health Polit Policy Law. 2001 Oct;26(5):1165-77. doi: 10.1215/03616878-26-5-1165.
5
Managing conflicts of interest in the conduct of clinical trials.在临床试验实施过程中管理利益冲突。
JAMA. 2002 Jan 2;287(1):78-84. doi: 10.1001/jama.287.1.78.
6
Medical innovation and institutional interdependence: rethinking university-industry connections.医学创新与机构间的相互依存关系：重新思考大学与产业界的联系
JAMA. 2002 Jan 2;287(1):72-7. doi: 10.1001/jama.287.1.72.
7
Goodbye to all that. The end of moderate protectionism in human subjects research.告别这一切。人类受试者研究中适度保护主义的终结。
Hastings Cent Rep. 2001 May-Jun;31(3):9-17.
8
Ethics behind closed doors: do research ethics committees need secrecy?闭门背后的伦理：研究伦理委员会需要保密吗？
BMJ. 2001 May 26;322(7297):1294-6. doi: 10.1136/bmj.322.7297.1294.
9
Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?药品监管的协调与竞争：欧盟药品审批体系的健康状况如何？
Soc Sci Med. 1999 Jun;48(11):1655-67. doi: 10.1016/s0277-9536(99)00042-8.
Zotero 插件